Knockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivo-Reference-Cited by-同舟云学术

Knockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivo

Published:2014-01 Issue:1 Volume:22 Page:92-101
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Dudek Henryk,Wong Darren H,Arvan Rokhand,Shah Anee,Wortham Kathleen,Ying Bo,Diwanji Rohan,Zhou Wei,Holmes Benjamin,Yang Hailin,Cyr Wendy A,Zhou Yi,Shah Aalok,Farkiwala Ruchir,Lee Michael,Li Yiting,Rettig Garrett R,Collingwood Michael A,Basu Sujit K,Behlke Mark A,Brown Bob D

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference43 articles.

1. Tyrosine kinase inhibitors: from rational design to clinical trials;Traxler;Med Res Rev,2001

2. Erlotinib hydrochloride;Minna;Nat Rev Drug Discov,2005

3. Raf pathway inhibitors in oncology;Bollag;Curr Opin Investig Drugs,2003

4. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions;Williams;Proc Natl Acad Sci USA,2003

5. Development of a second-generation antiandrogen for treatment of advanced prostate cancer;Tran;Science,2009

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA;Cell Biochemistry and Biophysics;2024-07-10

2. Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer;ACS Biomaterials Science & Engineering;2024-02-02

3. Targeting PKM2 improves the gemcitabine sensitivity of intrahepatic cholangiocarcinoma cells via inhibiting β-catenin signaling pathway;Chemico-Biological Interactions;2024-01

4. The Effect of Dicer Knockout on RNA Interference Using Various Dicer Substrate Small Interfering RNA (DsiRNA) Structures;Genes;2022-02-27

5. Drug loaded nanomaterials for hematological malignancies diagnosis and enhanced targeted therapy;Advanced Nanomaterials for Point of Care Diagnosis and Therapy;2022